Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) FCF Margin (2017 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed FCF Margin for 9 consecutive years, with 53051.17% as the latest value for Q1 2025.

  • On a quarterly basis, FCF Margin changed N/A to 53051.17% in Q1 2025 year-over-year; TTM through Sep 2025 was 97807.12%, a 5010949.0% decrease, with the full-year FY2024 number at 48193.56%, up 4100516.0% from a year prior.
  • FCF Margin was 53051.17% for Q1 2025 at Creative Medical Technology Holdings, up from 64984.53% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 1587.82% in Q3 2022 to a low of 64984.53% in Q4 2024.
  • A 5-year average of 23687.42% and a median of 18366.3% in 2024 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: soared 232007bps in 2022, then plummeted -4385839bps in 2023.
  • Creative Medical Technology Holdings' FCF Margin stood at 1714.05% in 2021, then plummeted by -1026bps to 19307.71% in 2022, then tumbled by -227bps to 63166.1% in 2023, then decreased by -3bps to 64984.53% in 2024, then grew by 18bps to 53051.17% in 2025.
  • Per Business Quant, the three most recent readings for CELZ's FCF Margin are 53051.17% (Q1 2025), 64984.53% (Q4 2024), and 18366.3% (Q2 2024).